CATEGORIES
CONTACT THE MEDIA TEAM
If you are a journalist with questions or an interview or media request, please do not hesitate to contact us.
by Bob Broeze on 10/26/15 9:30 AM Thought Leadership
CMC Biologics remains vigilant in meeting customers’ growing demand for scalable biologics production. Its continued investment in technological advances, innovative facility designs and rapid facility expansions benefits customers and drives growth. CMC Biologics is dedicated to its customers’ focus to bring effective, safe medicines to patients quickly – improving lives.
by Bob Broeze on 10/22/15 5:54 AM News
COPENHAGEN, Denmark– 22 October 2015 – CMC Biologics, Inc., a global leader in clinical and commercial manufacturing of therapeutic proteins, today announced that they have entered into an agreement with Immunocore Limited, a leading UK-based biotechnology company focused on developing new treatments for cancer, viral infections and autoimmune diseases, for the process transfer and cGMP production of IMCgp100, Immunocore’s lead product. IMCgp100 is a novel first-in-class cancer immunotherapeutic based on proprietary platform T- cell receptor (TCR) technology.
by Bob Broeze on 10/20/15 6:03 AM News
Copenhagen, Denmark, Seattle, WA, and Berkeley, CA, USA – October 20, 2015 – CMC Biologics, Inc., a global leader in commercial manufacturing of therapeutic proteins with operations in Copenhagen, Denmark, Seattle, Washington and Berkeley, CA USA, announced today the promotion of Gustavo Mahler, to be effective January 1st 2016, to serve as its Chief Executive Officer. CMC Biologics, a company with 500 employees globally, is committed to delivering world-class, fully integrated, biopharmaceutical process development and manufacturing services for clinical and commercially launched biological medicines.
by Bob Broeze on 10/7/15 6:06 AM News
Seattle, WA and Berkeley, CA USA, and Copenhagen, Denmark – October 7, 2015 – CMC Biologics, Inc., a global leader in commercial manufacturing of therapeutic proteins, officially marked the opening of its first-in-class Bioreactor 6Pack™ manufacturing facility with a ribbon cutting ceremony on Thursday, October 1, at its Bothell, Washington campus. Nearly 200 local political and business leaders attended the event.
AGC Biologics
US Phone: +1 425 485 1900
Denmark Phone: +45 7020 9470
General Inquiries: info@agcbio.com
Seattle
21511 23rd Dr. SE
Bothell, WA 98021 USA
Berkeley
890 Heinz Avenue
Berkeley, CA 94710 USA
Copenhagen
Vandtaarnsvej 83B, DK-2860 Soeborg
Copenhagen, Denmark
CVR: 25950941
© 2017 CMC Biologics All Rights Reserved
